Concepedia

Publication | Open Access

Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer

74

Citations

17

References

2017

Year

Abstract

EudraCT number: 2014-000349-59.

References

YearCitations

Page 1